Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Market Cap	2.19B -20.9%
Revenue (ttm)	939.78M -3.3%
Net Income	66.42M +13.2%
EPS	0.89 +13.5%
Shares Out	n/a
PE Ratio	33.01
Forward PE	n/a
Dividend	0.59 (2.06%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Average Volume	n/a
Open	28.40
Previous Close	28.60
Day's Range	28.40 - 28.40
52-Week Range	27.40 - 36.00
Beta	n/a
RSI	51.03
Earnings Date	Feb 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling g...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 3,615
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KOY

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial numbers in JPY